Efficacy and safety of Efgartigimod IV and PH20 SC in gMG: Analysis of AChR-Ab- participants in ADAPT+/ADAPT-SC+

Authors
Category Primary study
Conference10th Congress of the European Academy of Neurology
Year 2024
This article has no abstract
Epistemonikos ID: 9b605607844bc7e45b9b3b34da8e996fa5bacb71
First added on: Jan 07, 2026